Overview

A Pharmacokinetics (PK) and Safety Study of Oral Fampridine-PR 10 mg in Chinese, Japanese, and Caucasian Adult Healthy Volunteers

Status:
Completed

Trial end date:
2010-11-01

Target enrollment:

Participant gender:

Summary

The primary objective of the study is to determine the Pharmacokinetic (PK) and safety profiles of fampridine-PR 10 mg in Chinese and Japanese adult healthy volunteers. The secondary objective of this study is to compare the PK and safety profiles of fampridine-PR 10 mg among the Chinese, Japanese, and Caucasian adult healthy volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

Biogen

Collaborator:

Acorda Therapeutics

Treatments:

4-Aminopyridine